The Belgian pharmaceutical conference 2013

The program is built around 3 major themes: ?The Impatient patient?: bridging theory into practice? ?Biopharmaceuticals: high technological dedication that delivers? ?Healthcare in 2030: challenges and opportunities? Register online on the conference website(link is external). Program 08:00 ? 09:30 Welcome Coffee ? Exhibition Lounge 09:30 ? 09:45 Grand Opening ? Plenary room Laurette Onkelinx ? Minister of Public Health and Social Affairs (tbc) 09:45 ? 10:45 ?The Impatient Patient?: bridging theory into practice? ? Plenary room Chair: Jo De Cock ? CEO National Institute Health and Disability Insurance (NIHDI) Co-chair: Xavier De Cuyper ? CEO Federal Agency for Medicines and Health Products (FAHMP) Keynote speaker: Prof. Dr. Chantal Van Audenhove ? Director Lucas, Center for care research and consultancy at KU Leuven Debate with Ilse Weeghmans, Director Vlaams Pati?ntenplatform (VPP) 10:45 ? 11:15 Coffee break ? Exhibition Lounge 11:15 ? 12:30 ?Biopharmaceuticals: high technological dedication that delivers? ? Plenary room In partnership with Chair: Kurt Hertogs ? Global Head Community of Research Excellence & Advanced Technology, Janssen Pharmaceutica Keynote speaker: Prof. Theo Dingermann ? Institut f?r Pharmazeutische Biologie, Biozentrum,Frankfurt/Main Debate with Dr. Rudi Pauwels ? Founder and Executive chairman, Biocartis and Prof. Jean-Luc Balligand ? Director of the Unit of Pharmacology and Therapeutics, Universit? Catholique de Louvain (UCL) and Vice-Chairman of BioWin 12:30 ? 14:00 Lunch ? Exhibition Lounge 14:00 ? 16:00 Break-out Sessions ?Future perspective for drug device combos? Chair: Prof. Bruno Flamion (Prof. of Physiology & Pharmacology, Past Chair of the Scientific Advice Working Party at EMA & Past Chair of the Federal Committee for Reimbursement of Medicines at INAMI/RIZIV in Belgium) Rob Geraerdts (Expert Diagnostics) Nancy Van Lent (New Therapy Market Access Manager EMEA at Abbott Vascular) Claudio Rossi (Novartis) ?Biologicals versus Nonbiologicals in Exploratory Clinical Development? Chair: Prof. Dr. Jan deHoon (Chairman BAPU) & Dr. Maikel Raghoebar (Vice-Chairman BAPU) Bart van Hartingsveldt (Assistant Director Immunology Translational Medicine, Janssen Biologics Europe) Walter Janssens (Senior Non-Clinical Assessor & Coordinator Early Phase Development, FAMHP) Christian Duby (Medical Director at Ablynx nv) Prof. Dr. Paul Declerck (Faculty of Pharmaceutical Sciences, KU Leuven) "Upcoming challenges in Pharma ? the need to knows? Chair: Dr. Stefaan Vancayzeele (CSONovartis Pharma & President of BeAPP) & Dr. Greet Musch (Director-General, Pre-Authorization FAMPH) Dr. Greet Musch (Director-General, Pre-Authorization FAMPH) Prof. Jean-Michel Dogn? (Full Professor & Head of Department of Pharmacy at Namur University, Pharmacovigilance Expert at FAMHP and Belgian effective member of PRAC ? Pharmacovigilance Risk Assessment Committee ? of EMA) ?Where nanotechnology and biology meet: opportunities for new therapeutic solutions? Chair: Dr. Phil Goliber (Vice President Strategy and Portfolio UCB) Johan Van Helleputte (Senior VP Strategic Development) & Dr. Peter Peumans (Director Bio-Nanon Electronics & Director Life Science Technologies, IMEC ) 16:00 ? 16:45 Coffee break ? Exhibition Lounge 16:45 ? 17:30 ?Healthcare in 2030: challenges and opportunities? ? Plenary room Chair: Peter Guenter ? Senior Vice President, Europe Global Operations, Sanofi ? Keynote speaker: Dr. Richard Barker (Past CEO ABPI, CEO of ?2030: The future of Medicine? ? Keynote speaker: Luc De Bruyne (Senior Vice President Head, Europe Area, GlaxoSmithKline) on ?And what about pharmaceutical companies?? 17:30 ? 18:15 ?Healthcare in the future: flip, flux and fusion? ? Plenary room ? Keynote speaker: Peter Hinssen (CEO Across Technology) 18:15 ? 18:45 Announcement BPC Award 2014 ? Plenary room ? Introduction of BPC award ? Closing remarks ? Prof. Dr. Leo Neels 18:45 ? 20:00 Cocktail & networking ? Exhibition Lounge

Share with others